Evelo Biosciences, Inc.

Evelo Biosciences, Inc.

Evelo Biosciences, Inc.

Overview
Headquarters

620 Memorial Drive,Suite 200 West,Cambridge, MA 02139

Type of Company

Public

Employees (Worldwide)

98

Industries

Pharmaceuticals
Medical Support Services
Biotechnology

Company Description

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Evelo Biosciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founding Member

President, Chief Executive Officer & Director

General Counsel & Secretary

Chief Development Officer

Chief People Officer

Chief Medical Officer

Senior Vice President & Head-Research

Head of People & Operational Excellence

Head of Technical Operations

Global Head of Regulatory Affairs, EU Head of Clinical Development

Board of Directors

Executive Partner at Flagship Pioneering

President & Chief Executive Officer at Syros Pharmaceuticals, Inc.

Head, Department of Surgery & Cancer at Imperial College London - Faculty of Medicine

Chief Technical Operations & Quality Officer at Moderna, Inc.

Chairman at Better Therapeutics LLC

Chairman & Co-Chief Executive Officer at KSQ Therapeutics, Inc.

President, Chief Executive Officer & Director at Evelo Biosciences, Inc.

Co-Founder at Exelixis, Inc.

Paths to Evelo Biosciences, Inc.
Potential Connections via
Relationship Science
You
Evelo Biosciences, Inc.
Recent Transactions
Details Hidden

Evelo Biosciences, Inc. issued USD Common Stock

Details Hidden

Evelo Biosciences, Inc. issued USD Common Stock

Details Hidden

Evelo Biosciences, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Transaction Advisors
Escrow Agent

Advised onEvelo Biosciences, Inc. issued USD Common Stock

Underwriter

Advised onEvelo Biosciences, Inc. issued USD Common Stock

Underwriter

Advised onEvelo Biosciences, Inc. issued USD Common Stock

Legal Advisor

Advised onEvelo Biosciences, Inc. issued USD Common Stock

Legal Advisor

Advised onEvelo Biosciences, Inc. issued USD Common Stock

Associate

Advised onEvelo Biosciences, Inc. issued USD Common Stock

Key Stats and Financials As of 2019
Market Capitalization
$558M
Total Enterprise Value
$71.9M
Earnings Per Share
$-2.67
Revenue
$0
Net Profit
$-85.5M
EBITDA
$-84.6M
Total Debt
$19.6M
Total Equity
$60.2M
TEVNet Income
-0.84x
Debt TEV
0.27x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Non-Profit Donations & Grants
Investors
Details Hidden

FMR help over 32 million people feel more confident in their most important financial goals, manage employee benefit programs for over 22,000 businesses, and support more than 13,000 financial institutions with innovative investment and technology solutions to grow their businesses.

Details Hidden

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Details Hidden

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies

Suppliers
The University of Chicago Legal | Chicago, IL

UCE’s Office of Investments is responsible for managing the University's investment assets, which includes overseeing the endowment to ensure that it benefits both current and future generations of the University of Chicago. They oversee the broad investment strategy and provide input to the development of the strategic and tactical investment policies of the University & UCMC endowments, pension plans and self-insurance trust assets. Their strategy combines qualitative and quantitative analysis, seeking to achieve superior investment performance on a risk-adjusted basis.

Mayo Clinic Hospitals & Patient Services

The Mayo Clinic is a nonprofit academic medical center based in Rochester, Minnesota, focused on integrated clinical practice, education, and research. It employs more than 4,500 physicians and scientists and 58,400 administrative and allied health staff. The practice specializes in treating difficult cases through tertiary care. It spends over $660 million a year on research and employs over 3,000 full-time research personnel.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Evelo Biosciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Evelo Biosciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Evelo Biosciences, Inc..